Pharmacy Times says USP standards matter more as peptides go mainstream
The trade piece frames compounding standards and quality documentation as the dividing line between clinical peptide use and gray-market supply.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 21 19:10 ETSource: Pharmacy Times
The wire
- 01Pharmacy Times argues that USP compounding standards carry growing weight as peptide prescribing moves from niche clinics into mainstream pharmacy practice.
- 02Pharmacists and compounders weighing peptide orders face questions about sourcing, beyond-use dating and documentation that USP chapters are meant to answer.
- 03The article is commentary rather than a regulatory action, and does not report new FDA guidance or enforcement on peptide compounding.
From the source
Read at pharmacytimes.comAs Peptides Go Mainstream, USP and Matter More Than Ever
